RobertPWhiteheadMD

Oncology • Goodyear, AZ

Medical Oncologist at Cancer Treatment Centers of America

Join to view full profile

Are you Dr. Whitehead?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
14200 W Celebrate Life Way

Goodyear, AZ 85338
Phone+1 623-207-3372

Fax+1 623-207-3921

Summary

Dr. Robert Whitehead, MD is an oncologist in Goodyear, Arizona. He is currently licensed to practice medicine in Arizona, Minnesota, and Nevada. He is affiliated with City of Hope Phoenix.

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1977 - 1979
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1975 - 1977
University of MarylandInternship, Internal Medicine, 1971 - 1972
University of Maryland School of MedicineClass of 1971

Certifications & Licensure

AZ State Medical License 2013 - 2026
MN State Medical License 2020 - 2025
NV State Medical License 2010 - 2025
TX State Medical License 1995 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed Start of enrollment: 1993 Oct 01
Terminated
Phase 3
S9804: Vinorelbine in Treating Patients With Stage IV Melanoma Start of enrollment: 1999 May 01
Completed
Phase 2
S9923 R115777 in Treating Patients With Advanced Colorectal Cancer Start of enrollment: 2000 Jun 01
Completed
Phase 2
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract Start of enrollment: 2002 Jul 01
Terminated
Phase 2
BMS-247550 in Treating Patients With Advanced Pancreatic Cancer Start of enrollment: 2001 Jul 01
Completed
Phase 2
S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum Start of enrollment: 2004 Aug 01
Withdrawn
Phase 2
FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer Start of enrollment: 2004 Apr 01
Completed
Phase 2
SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer Start of enrollment: 1993 Jul 01
Completed
Join now to see all

Publications & Presentations

PubMed

113 citations
A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study.
John S. Macdonald, Sheryl McCoy, Robert P. Whitehead, Syma Iqbal, James L. Wade
Investigational New Drugs. 2005-10-01
68 citations
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II...
Philip A. Philip, Bryan Goldman, Ramesh K. Ramanathan, Heinz-Josef Lenz, Andrew M. Lowy
Cancer. 2014-10-01
18 citations
A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.
Robert P. Whitehead, Thomas R. Fleming, John S. Macdonald, Phyllis J. Goodman, John R. Neefe
Journal of Biological Response Modifiers. 1990-12-01